-
-
Call more information
660-596-2224 -
A Change in Opioid Prescribing In the latest change to controlled substance prescribing, hydrocodone has moved to Schedule II among controlled substances. In recognition of well-publicized reports that 99% of the worldwide supply of hydrocodone in 2007 was consumed in the United States,[1] the US Drug Enforcement Administration (DEA) enacted the Final Rule on October […]
Read MorePublished in Clin Respir J. 2014 Oct 13 Authors: Aydın V et al BACKGROUND AND AIMS: Laparoscopic cholecystectomy has many advantages such as shorter hospital stay of patients, minimal postoperative pain, rapid recovery after the operation; however, systemic disadvantages because intra-abdominal pressure, position and general anaesthesia may also appear. In this study, pressure-controlled ventilation (PCV) […]
Read MoreWhether you’re managing a new team as a result of a promotion, job change or an organizational restructure, stepping in to lead a pre-existing team (and the established dynamics, group norms, systems and expectations they tend to possess) demands a sound management strategy. Here are a few expert tips on how to manage a team, […]
Read MoreEpidural steroid injections (ESIs) should be contraindicated under certain circumstances in the management of back pain, the US Food and Drug Administration’s (FDA’s) Anesthetic and Analgesic Drug Products Advisory Committee has concluded. After 2 days of presentations and discussions, committee members agreed that injecting a particulate steroid in the cervical region, using the transforaminal approach, […]
Read MoreISSUE: Baxter International Inc. voluntarily recalled one lot of Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL to the user level due to a complaint of mislabeling of the overpouch. Some containers of Product Code 2B0826, Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL, Lot Number P319160, Exp. 06/30/2015, NDC 0338-0709-48 […]
Read More